| Code | Description | Claims | Beneficiaries | Total Paid |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
17,581 |
17,210 |
$1.70M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
11,138 |
10,707 |
$1.55M |
| T1015 |
Clinic visit/encounter, all-inclusive |
20,164 |
18,907 |
$1.33M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
2,952 |
2,689 |
$561K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
6,445 |
6,178 |
$530K |
| G0378 |
Hospital observation service, per hour |
1,034 |
509 |
$478K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
5,095 |
4,414 |
$331K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
5,348 |
4,491 |
$329K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
6,910 |
6,137 |
$321K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
6,291 |
6,184 |
$286K |
| X0616 |
|
1,035 |
1,008 |
$264K |
| 80053 |
Comprehensive metabolic panel |
24,535 |
22,894 |
$236K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
3,940 |
3,755 |
$168K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
22,098 |
20,128 |
$108K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
606 |
591 |
$106K |
| 84443 |
Thyroid stimulating hormone (TSH) |
4,421 |
4,333 |
$86K |
| 80061 |
Lipid panel |
6,020 |
5,957 |
$78K |
| X0621 |
|
357 |
207 |
$78K |
| 80050 |
General health panel |
1,372 |
1,352 |
$68K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
2,284 |
2,167 |
$68K |
| X0620 |
|
257 |
233 |
$67K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
248 |
245 |
$64K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
561 |
364 |
$59K |
| 87428 |
|
2,091 |
2,058 |
$57K |
| 71045 |
Radiologic examination, chest; single view |
3,813 |
3,652 |
$53K |
| G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed |
707 |
651 |
$52K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
6,213 |
5,668 |
$48K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
599 |
594 |
$47K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
484 |
478 |
$46K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
1,466 |
1,450 |
$42K |
| 70450 |
Computed tomography, head or brain; without contrast material |
667 |
643 |
$42K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
2,357 |
2,175 |
$41K |
| 0001A |
|
981 |
980 |
$41K |
| 71046 |
Radiologic examination, chest; 2 views |
1,656 |
1,621 |
$41K |
| 0002A |
|
978 |
968 |
$40K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
1,153 |
1,149 |
$37K |
| G0482 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed |
323 |
277 |
$37K |
| 85027 |
|
5,522 |
5,034 |
$33K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
327 |
316 |
$30K |
| 84703 |
|
3,372 |
3,225 |
$29K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,215 |
1,179 |
$29K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,213 |
1,178 |
$28K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
684 |
517 |
$28K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,395 |
1,291 |
$27K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
278 |
176 |
$27K |
| 76830 |
Ultrasound, transvaginal |
476 |
473 |
$23K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
3,210 |
2,955 |
$22K |
| 84484 |
|
3,039 |
2,655 |
$20K |
| 78815 |
Positron emission tomography (PET) for limited area imaging |
24 |
24 |
$19K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
243 |
240 |
$19K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
1,517 |
1,320 |
$19K |
| 93976 |
|
239 |
237 |
$19K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
599 |
565 |
$19K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
73 |
72 |
$16K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,481 |
2,448 |
$16K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,386 |
2,045 |
$15K |
| 84481 |
|
653 |
642 |
$15K |
| 81001 |
|
5,696 |
5,425 |
$15K |
| 95811 |
|
26 |
26 |
$14K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
91 |
91 |
$14K |
| 20553 |
|
319 |
306 |
$14K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,155 |
992 |
$14K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
503 |
497 |
$14K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
271 |
270 |
$13K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
224 |
219 |
$12K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
586 |
581 |
$12K |
| 80306 |
|
1,029 |
980 |
$12K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
215 |
213 |
$12K |
| 86618 |
|
515 |
504 |
$11K |
| 88342 |
|
334 |
306 |
$11K |
| 82607 |
|
909 |
896 |
$11K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
605 |
335 |
$11K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
272 |
266 |
$11K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
712 |
641 |
$10K |
| 82728 |
|
946 |
913 |
$10K |
| 84439 |
|
1,219 |
1,195 |
$10K |
| 93971 |
|
154 |
153 |
$10K |
| 86780 |
|
615 |
607 |
$9K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
115 |
113 |
$8K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
42 |
40 |
$8K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
47 |
47 |
$8K |
| 0004A |
|
199 |
195 |
$8K |
| 83540 |
|
1,084 |
1,046 |
$8K |
| 83690 |
|
1,816 |
1,718 |
$8K |
| 76642 |
|
165 |
154 |
$8K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
295 |
288 |
$7K |
| 76536 |
|
152 |
150 |
$7K |
| 88313 |
|
213 |
211 |
$7K |
| 87340 |
|
499 |
494 |
$7K |
| 88312 |
|
169 |
167 |
$7K |
| G0472 |
Hepatitis c antibody screening, for individual at high risk and other covered indication(s) |
301 |
296 |
$7K |
| 87186 |
|
871 |
823 |
$6K |
| 73030 |
|
374 |
355 |
$6K |
| 73564 |
|
270 |
243 |
$6K |
| 86038 |
|
415 |
407 |
$6K |
| 73610 |
|
350 |
342 |
$6K |
| 83880 |
|
268 |
248 |
$6K |
| 87077 |
|
868 |
821 |
$6K |
| 82570 |
|
832 |
811 |
$6K |
| 86762 |
|
296 |
292 |
$6K |
| 73630 |
|
456 |
438 |
$6K |
| 59025 |
Fetal non-stress test |
288 |
233 |
$5K |
| 87040 |
|
624 |
336 |
$5K |
| 84153 |
|
227 |
220 |
$5K |
| 80076 |
|
594 |
578 |
$5K |
| 84146 |
|
221 |
199 |
$5K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
97 |
83 |
$5K |
| 95806 |
|
80 |
80 |
$5K |
| 84702 |
|
306 |
248 |
$5K |
| 95886 |
|
132 |
131 |
$5K |
| 85610 |
|
1,997 |
1,329 |
$5K |
| 76775 |
|
117 |
115 |
$5K |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
538 |
515 |
$4K |
| 86900 |
|
568 |
541 |
$4K |
| 82746 |
|
371 |
367 |
$4K |
| 36415 |
Collection of venous blood by venipuncture |
4,106 |
3,348 |
$4K |
| 85652 |
|
1,515 |
1,444 |
$4K |
| 86140 |
|
1,416 |
1,383 |
$4K |
| 81003 |
|
1,597 |
1,439 |
$4K |
| 82043 |
|
531 |
522 |
$4K |
| 12001 |
|
71 |
71 |
$4K |
| 83735 |
|
772 |
606 |
$4K |
| 86850 |
|
507 |
485 |
$4K |
| 83550 |
|
889 |
855 |
$4K |
| 73130 |
|
323 |
296 |
$4K |
| 86235 |
|
83 |
81 |
$4K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
1,643 |
1,464 |
$4K |
| 96523 |
|
232 |
188 |
$4K |
| 76801 |
|
82 |
79 |
$4K |
| 87070 |
|
622 |
578 |
$4K |
| 72110 |
|
161 |
160 |
$4K |
| 86160 |
|
126 |
123 |
$4K |
| 87522 |
Neg quan hep c or qual rna |
93 |
87 |
$4K |
| 85730 |
|
691 |
627 |
$4K |
| 82565 |
|
598 |
578 |
$4K |
| 85379 |
|
449 |
437 |
$4K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
6,306 |
5,459 |
$3K |
| 72100 |
|
312 |
279 |
$3K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
17 |
17 |
$3K |
| 87075 |
|
374 |
337 |
$3K |
| 93017 |
|
90 |
87 |
$3K |
| 74018 |
|
231 |
224 |
$3K |
| 73562 |
|
161 |
149 |
$3K |
| 80164 |
|
178 |
163 |
$3K |
| 86800 |
|
146 |
142 |
$3K |
| 84145 |
|
211 |
202 |
$3K |
| 83605 |
|
535 |
459 |
$3K |
| 86431 |
|
350 |
344 |
$3K |
| 87210 |
|
425 |
416 |
$3K |
| 94664 |
|
331 |
254 |
$2K |
| 86901 |
|
572 |
543 |
$2K |
| 87807 |
|
191 |
186 |
$2K |
| 90715 |
|
483 |
468 |
$2K |
| G0145 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision |
153 |
149 |
$2K |
| 93970 |
|
29 |
27 |
$2K |
| 73110 |
|
184 |
178 |
$2K |
| 84403 |
|
74 |
74 |
$2K |
| 83001 |
|
110 |
110 |
$2K |
| 96367 |
|
72 |
40 |
$2K |
| 83615 |
|
315 |
236 |
$2K |
| 73502 |
|
102 |
100 |
$2K |
| 86376 |
|
228 |
221 |
$2K |
| 82550 |
|
334 |
301 |
$2K |
| 82784 |
|
93 |
87 |
$2K |
| 71250 |
|
37 |
36 |
$2K |
| 86039 |
|
130 |
128 |
$2K |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
99 |
99 |
$2K |
| 84550 |
|
305 |
254 |
$2K |
| 0071A |
|
45 |
45 |
$2K |
| 86706 |
|
122 |
122 |
$2K |
| 87081 |
|
282 |
281 |
$2K |
| J2704 |
Injection, propofol, 10 mg |
2,960 |
2,632 |
$1K |
| 84460 |
|
202 |
197 |
$1K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
3,527 |
3,131 |
$1K |
| 84450 |
|
201 |
196 |
$1K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
198 |
196 |
$1K |
| P9604 |
Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge |
613 |
459 |
$1K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
12 |
12 |
$1K |
| 83970 |
|
44 |
42 |
$1K |
| J1756 |
Injection, iron sucrose, 1 mg |
246 |
112 |
$1K |
| 85007 |
|
336 |
289 |
$1K |
| 77066 |
Tomosynthesis, mammo |
13 |
13 |
$1K |
| 94060 |
|
38 |
38 |
$1K |
| 83721 |
|
111 |
110 |
$1K |
| 0072A |
|
29 |
28 |
$1K |
| J3490 |
Unclassified drugs |
2,244 |
1,863 |
$1K |
| 86200 |
|
78 |
77 |
$1K |
| 84100 |
|
210 |
159 |
$1K |
| 84402 |
|
39 |
39 |
$1K |
| 93271 |
|
16 |
16 |
$1K |
| 80074 |
|
26 |
25 |
$1K |
| 84165 |
|
77 |
73 |
$1K |
| 84156 |
|
253 |
241 |
$935.26 |
| 87102 |
|
98 |
97 |
$931.67 |
| 72050 |
|
31 |
31 |
$880.47 |
| 82950 |
|
133 |
133 |
$863.95 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
4,586 |
4,116 |
$859.09 |
| 86225 |
|
64 |
64 |
$846.13 |
| 82962 |
|
777 |
544 |
$779.60 |
| 80178 |
|
108 |
102 |
$754.59 |
| 82248 |
|
120 |
108 |
$746.10 |
| 80069 |
|
134 |
98 |
$727.79 |
| 83002 |
|
40 |
40 |
$691.13 |
| 94729 |
|
26 |
26 |
$673.95 |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
25 |
24 |
$658.95 |
| 86787 |
|
38 |
38 |
$653.01 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
416 |
380 |
$650.38 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
3,876 |
3,225 |
$650.17 |
| 97597 |
|
15 |
12 |
$648.21 |
| 81002 |
|
200 |
197 |
$578.07 |
| 84520 |
|
129 |
122 |
$574.82 |
| 3044F |
|
1,076 |
1,067 |
$542.56 |
| 86705 |
|
40 |
40 |
$507.81 |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
14 |
14 |
$462.15 |
| 94727 |
|
24 |
24 |
$446.37 |
| 73590 |
|
29 |
28 |
$397.15 |
| 84681 |
|
12 |
12 |
$395.19 |
| 82533 |
|
29 |
24 |
$386.60 |
| 80299 |
|
22 |
20 |
$383.28 |
| 87046 |
|
42 |
38 |
$374.93 |
| 71101 |
|
28 |
28 |
$360.68 |
| 86592 |
|
89 |
89 |
$349.50 |
| 82670 |
|
16 |
16 |
$324.30 |
| 87076 |
|
24 |
24 |
$321.19 |
| 73080 |
|
25 |
25 |
$312.99 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
159 |
124 |
$304.37 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
685 |
517 |
$291.84 |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
13 |
12 |
$276.55 |
| 87045 |
|
41 |
38 |
$252.29 |
| 82103 |
|
14 |
14 |
$252.24 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
4,479 |
3,842 |
$235.39 |
| 82947 |
|
56 |
55 |
$199.89 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
1,293 |
1,064 |
$197.35 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
156 |
117 |
$182.89 |
| 81025 |
|
42 |
41 |
$177.60 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
1,100 |
1,010 |
$168.89 |
| 86708 |
|
12 |
12 |
$168.18 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
2,096 |
1,777 |
$161.83 |
| 93270 |
|
16 |
16 |
$142.59 |
| 72202 |
|
12 |
12 |
$138.60 |
| 82390 |
|
12 |
12 |
$131.00 |
| 82330 |
|
15 |
14 |
$112.49 |
| 76000 |
|
74 |
70 |
$96.60 |
| 85046 |
|
15 |
14 |
$89.34 |
| J2060 |
Injection, lorazepam, 2 mg |
360 |
297 |
$88.95 |
| 84155 |
|
45 |
42 |
$88.89 |
| 73140 |
|
13 |
13 |
$86.40 |
| A6021 |
Collagen dressing, sterile, size 16 sq. in. or less, each |
19 |
13 |
$85.00 |
| 36591 |
|
23 |
13 |
$82.15 |
| A6212 |
Foam dressing, wound cover, sterile, pad size 16 sq. in. or less, with any size adhesive border, each dressing |
34 |
27 |
$80.40 |
| A4606 |
Oxygen probe for use with oximeter device, replacement |
326 |
323 |
$73.92 |
| 88304 |
|
30 |
28 |
$61.10 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
48 |
42 |
$59.95 |
| 82010 |
|
13 |
12 |
$53.06 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
410 |
318 |
$52.93 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
17 |
12 |
$52.11 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
2,004 |
1,755 |
$50.15 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
361 |
303 |
$46.49 |
| J1644 |
Injection, heparin sodium, per 1000 units |
253 |
119 |
$41.66 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
15 |
12 |
$41.17 |
| 94760 |
|
119 |
83 |
$38.16 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
846 |
749 |
$36.88 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
274 |
216 |
$35.25 |
| 72020 |
|
30 |
25 |
$34.72 |
| 3051F |
|
110 |
109 |
$12.36 |
| J7050 |
Infusion, normal saline solution, 250 cc |
81 |
62 |
$11.08 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
20 |
13 |
$3.04 |
| C9399 |
Unclassified drugs or biologicals |
18 |
14 |
$0.00 |
| 3052F |
|
47 |
47 |
$0.00 |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
16 |
13 |
$0.00 |
| 72040 |
|
14 |
14 |
$0.00 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
38 |
35 |
$0.00 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
12 |
12 |
$0.00 |
| 3046F |
|
81 |
80 |
$0.00 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
115 |
101 |
$0.00 |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
15 |
12 |
$0.00 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
42 |
38 |
$0.00 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
34 |
30 |
$0.00 |